Date Title Description PDF
23 Feb 2022 About corporate governance The Company informs about the agreements adopted by the Board of Directors  Download
22 Feb 2022 On buy-back programmes ROVI reports the end of the share buy-back programme, effective as of 3 November 2021, and the launching of a new share buy-back programme, effective as of 23 February 2022.     Download
16 Feb 2022 On business and financial situation Moderna and ROVI announced that they expand their long-term collaboration for the manufacture of mRNA medicines over the next ten years       Download
03 Nov 2021 On buy-back programmes The Company reports the commencement, effective as of today, 3 November 2021, of a share buyback program. Download
16 Jul 2021 On Corporate Governance ROVI announces the appointment of Juan López-Belmonte Encina as Chairman of the Company   Download

Pages

Date Title Description PDF
26 Feb 2020 Annual Corporate Governance Report ROVI releases the 2019 Annual Corporate Governance Report Download
26 Feb 2020 Annual Report regarding remuneration of the members of the Board of Directors ROVI releases the 2019 annual report regarding remuneration of the members of the Board of Directors  Download

Pages

Date Title Description PDF
28 Jul 2016 Información sobre resultados (2) ROVI releases the press release related to the 2016 first half results Download
28 Jul 2016 Información sobre resultados ROVI releases the presentation related to the 2016 first half results Download
05 Jul 2016 Contratos de liquidez y contrapartida Liquidity contract: transactions conducted in the second quarter of 2016 Download
24 Jun 2016 Información sobre dividendos The Company informs about the dividends payment Download
31 May 2016 Convocatorias y acuerdos de Juntas y Asambleas generales ROVI releases the information related to the agreements adopted by the 2016 General Shareholders Meeting Download

Pages